Simmitecan Hydrochloride manufacturers
|
| | Simmitecan Hydrochloride Basic information |
| | Simmitecan Hydrochloride Chemical Properties |
| | Simmitecan Hydrochloride Usage And Synthesis |
| Uses | Simmitecan hydrochloride, a 9-substituted lipophilic Camptothecin (HY-16560) derivative, is a potent topoisomerase I inhibitor. Simmitecan hydrochloride is an anticancer agent[1][2]. | | in vivo | Simmitecan hydrochloride (3.75, 7.5 and 15 mg/kg, i.v. bolus) shows mean elimination half-life t1/2 of approximately 1.4 h in SD rats[2].
| | References | [1] Rini B, et al. A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma. Ann Oncol. 2014 Sep;25(9):1794-1799. DOI:10.1093/annonc/mdu212
[2] Hu ZY, et al. Pharmacokinetic evaluation of the anticancer prodrug simmitecan in different experimental animals. Acta Pharmacol Sin. 2013 Nov;34(11):1437-48. DOI:10.1038/aps.2013.74 |
| | Simmitecan Hydrochloride Preparation Products And Raw materials |
|